Drug Type Enzyme |
Synonyms a modified version of a leucine decarboxylase enzyme from Planctomycetaceae bacterium, CDX-6210 |
Target- |
Mechanism Enzyme replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Maple Syrup Urine Disease | Preclinical | US | 12 Aug 2021 |